STRS OHIO - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 1.2%.

Quarter-by-quarter ownership
STRS OHIO ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$52
-58.7%
48,9000.0%0.00%
-100.0%
Q2 2023$126
-77.2%
48,900
-63.9%
0.00%0.0%
Q1 2023$552
+144.2%
135,300
+200.0%
0.00%0.0%
Q4 2022$226
-100.0%
45,1000.0%0.00%
-66.7%
Q3 2022$589,000
-2.6%
45,100
-4.4%
0.00%0.0%
Q2 2022$605,000
-11.5%
47,200
+5.1%
0.00%0.0%
Q1 2022$684,000
-14.0%
44,9000.0%0.00%0.0%
Q4 2021$795,000
+14.4%
44,900
+35.6%
0.00%0.0%
Q3 2021$695,000
-15.2%
33,100
-20.4%
0.00%0.0%
Q2 2021$820,000
+24.4%
41,600
+83.3%
0.00%
+50.0%
Q1 2021$659,000
+42.3%
22,700
+48.4%
0.00%0.0%
Q4 2020$463,000
+90.5%
15,3000.0%0.00%
+100.0%
Q3 2020$243,000
-19.5%
15,3000.0%0.00%0.0%
Q2 2020$302,000
+85.3%
15,300
+15.0%
0.00%0.0%
Q1 2020$163,000
-33.5%
13,3000.0%0.00%0.0%
Q4 2019$245,000
+410.4%
13,300
+269.4%
0.00%
Q3 2019$48,000
+84.6%
3,600
+100.0%
0.00%
Q2 2019$26,0001,8000.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,766,666$59,928,00049.90%
Greenspring Associates, LLC 1,573,357$25,032,00038.95%
Svennilson Peter 18,017,932$286,665,00023.39%
Aquilo Capital Management, LLC 1,018,334$16,202,0001.72%
Jasper Ridge Partners, L.P. 308,750$4,912,0000.28%
Samsara BioCapital, LLC 36,451$580,0000.16%
Rock Springs Capital Management LP 360,454$5,735,0000.15%
Point72 Asset Management, L.P. 1,611,850$25,645,0000.13%
Virtus ETF Advisers LLC 14,880$237,0000.12%
WELD CAPITAL MANAGEMENT LLC 15,238$242,0000.10%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders